These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10824547)

  • 21. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
    Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for lung cancer: practice and promise.
    Vattemi E; Claudio PP
    Ann Ital Chir; 2004; 75(3):279-89. PubMed ID: 15605515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
    Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
    Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model.
    Zhang WW; Roth JA
    In Vivo; 1994; 8(5):755-69. PubMed ID: 7727723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
    Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
    Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for endometrial carcinoma with the herpes simplex thymidine kinase gene.
    Ural AU; Takebe N; Adhikari D; Ercikan-Abali E; Banerjee D; Barakat R; Bertino JR
    Gynecol Oncol; 2000 Mar; 76(3):305-10. PubMed ID: 10684701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal gene therapy for malignant leptomeningeal neoplasia.
    Ram Z; Walbridge S; Oshiro EM; Viola JJ; Chiang Y; Mueller SN; Blaese RM; Oldfield EH
    Cancer Res; 1994 Apr; 54(8):2141-5. PubMed ID: 8174120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
    Mineishi S; Nakahara S; Takebe N; Banerjee D; Zhao SC; Bertino JR
    Gene Ther; 1997 Jun; 4(6):570-6. PubMed ID: 9231073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis.
    Beltinger C; Fulda S; Kammertoens T; Uckert W; Debatin KM
    Cancer Res; 2000 Jun; 60(12):3212-7. PubMed ID: 10866313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prostate cancer gene therapy].
    Nasu Y; Kumon H
    Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
    Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.
    van der Eb MM; Cramer SJ; Vergouwe Y; Schagen FH; van Krieken JH; van der Eb AJ; Borel Rinkes IH; van de Velde CJ; Hoeben RC
    Gene Ther; 1998 Apr; 5(4):451-8. PubMed ID: 9614568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies.
    Aghi M; Chou TC; Suling K; Breakefield XO; Chiocca EA
    Cancer Res; 1999 Aug; 59(16):3861-5. PubMed ID: 10463570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y; Gilbert JD; Kim JH; Freytag SO
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The strategy of cancer gene therapy].
    Ito Y; Niitsu Y
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1780-8. PubMed ID: 9279113
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma.
    Hoganson DK; Batra RK; Olsen JC; Boucher RC
    Cancer Res; 1996 Mar; 56(6):1315-23. PubMed ID: 8640820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53.
    Pataer A; Fanale MA; Roth JA; Swisher SG; Hunt KK
    Cancer Gene Ther; 2006 Aug; 13(8):806-14. PubMed ID: 16628227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements.
    Kumagai T; Tanio Y; Osaki T; Hosoe S; Tachibana I; Ueno K; Kijima T; Horai T; Kishimoto T
    Cancer Res; 1996 Jan; 56(2):354-8. PubMed ID: 8542591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.